Company news
Annexon, Inc. news in 2020
Annexon, Inc.'s news releases, calls and decks from 2020, newest first.
Annexon Announces Initiation of Phase 2/3 Trial of ANX005 in Patients with Guillain-Barré Syndrome
December 20, 2020
Annexon Biosciences Reports Third Quarter 2020 Financial Results and Recent Business Highlights
November 15, 2020
Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program
November 11, 2020
Annexon Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
September 7, 2020
Annexon Biosciences Expands Leadership Team with the Appointment of Michael Overdorf as Chief Business Officer
July 29, 2020
Annexon Announces Closing of Initial Public Offering
July 27, 2020